CFTR and metabolic disease: Despite several reports relating GRK5 expression levels with neurodegenerative, cardiovascular, and metabolic diseases,66 we have not found significant alterations in GRK5 mRNA when comparing cells expressing wt- or p.Phe508del-CFTR (Figure S8B) or across DMSO versus 9g or ETI.